Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Annovis Bio Inc.

Start price
Target price
Perf. (%)
€10.94
10.04.24
-
10.04.25
1.46%
14.04.24

Risky Investment
buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.72
11.04.24
-
11.04.25
-12.21%
14.04.24

Could be worthwhile Investment >10% per year
buy
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€11.00
02.04.24
-
02.04.25
0.91%
14.04.24

Risky Investment
Nel ASA

Start price
Target price
Perf. (%)
€0.41
21.03.24
-
21.03.25
10.89%
14.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€11.00
02.04.24
-
02.04.25
0.91%
14.04.24

buy
Helma Eigenheimbau AG

Start price
Target price
Perf. (%)
€1.01
12.04.24
-
12.04.25
-1.19%
14.04.24

buy
Cancom SE

Start price
Target price
Perf. (%)
€27.94
01.04.24
€29.00
01.04.25
8.16%
14.04.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€61.72
26.03.24
€62.00
26.03.25
-2.20%
14.04.24

Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€166.46
28.03.24
€170.00
28.03.25
4.79%
14.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€2.42
19.02.24
€2.00
19.02.25
-37.87%
14.04.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€176.38
22.01.24
€180.00
22.01.25
-6.23%
14.04.24

positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
buy
Hugo Boss AG ADR

Start price
Target price
Perf. (%)
€12.90
22.11.23
€13.00
22.11.24
-22.48%
14.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
EBIT growth >5% per year expected
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€1.71
03.04.24
-
03.04.25
-2.92%
14.04.24

buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€2.02
03.04.24
-
03.04.25
-2.72%
14.04.24

Could be worthwhile Investment >10% per year
buy
Msp Recovery Inc.

Start price
Target price
Perf. (%)
€1.31
09.04.24
-
09.04.25
-19.08%
14.04.24

Mediaco Holding Inc.

Start price
Target price
Perf. (%)
€4.42
10.04.24
-
10.04.25
-32.13%
14.04.24

Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.50
11.04.24
-
11.04.25
3.27%
14.04.24

Risky Investment
Mediaco Holding Inc.

Start price
Target price
Perf. (%)
€4.26
05.04.24
-
05.04.25
-29.58%
14.04.24

Risky Investment
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€66.50
07.04.24
-
07.04.25
0.75%
14.04.24

Could be very worthwhile Investment >20% year
Eco Wave Power Global Ab

Start price
Target price
Perf. (%)
€3.84
08.04.24
-
08.04.25
-7.29%
14.04.24

Risky Investment
Helma Eigenheimbau AG

Start price
Target price
Perf. (%)
€1.65
11.04.24
-
11.04.25
-39.33%
14.04.24

Risky Investment
buy
Generac Holdings Inc.

Start price
Target price
Perf. (%)
€109.65
21.03.24
-
21.03.25
14.32%
14.04.24

buy
Salesforce.com

Start price
Target price
Perf. (%)
€280.20
13.03.24
-
13.04.24
-1.86%
14.04.24

buy
Zalando SE

Start price
Target price
Perf. (%)
€22.58
13.03.24
-
13.04.24
16.03%
14.04.24

buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€252.10
13.03.24
-
13.04.24
-12.53%
14.04.24